TransCode Therapeutics
NASDAQ: RNAZ
$1.66
as on
TransCode Therapeutics Stock Performance
as on September 15, 2026 at 6:59 am IST
Day's Low
Day's High
$1.65$1.72
0.60%
Downside
3.61%
Upside
52 Week's Low
52 Week's High
$1.63$20.992.02%
Downside
1164.46%
Upside
TransCode Therapeutics share price movements today
- Previous Close
- $1.69
- Open
- $1.71
- Volume
- 232.4K
- Market Cap
- $1.8M
- Day's Low - High
- $1.65 - $1.72
- 52 Week Low - High
- $1.63 - $20.99
TransCode Therapeutics Historical Returns
- 1 Month Return
- -48.48 %
- 3 Month Return
- -68.29 %
- 1 Year Return
- -84.21 %
- 3 Year Return
- -99.99 %
- 5 Year Return
- -100 %
TransCode Therapeutics Stock Fundamentals & Key Indicators
Check TransCode Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8M
EPS (TTM)
-48.65
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.07
Industry PE ratio
-1.78
PEG Ratio
-0.0009369070507744949
EBITDA
-39.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-99.39%
TransCode Therapeutics Stock Valuation
Track how TransCode Therapeutics P/E has moved over time to understand its valuation trends.
TransCode Therapeutics in the last 5 years
Lowest (-2022.71x)
March 31, 2022
Industry (-1.78x)
December 31, 2025
Today (-0.13x)
December 31, 2025
Highest (-0.13x)
December 31, 2025
Today’s Price to Earnings Ratio: -0.13x
TransCode Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of TransCode Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $1.8M | -100% | -0.07 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $130.6B | 173.57% | 29.76 | 86.04% | NA | |
| BUY | $57.5B | -66.34% | -18.04 | -12.57% | NA | |
| BUY | $80.5B | 21.13% | 18.66 | 84.86% | 47.339999999999996% |
Stock Returns calculator for TransCode Therapeutics Stock including INR - Dollar returns
The TransCode Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
TransCode Therapeutics investment value today
Current value as on today
₹16,820
Returns
Returns from TransCode Therapeutics Stock
Dollar Impact
₹1,306 (+1.31%)
Analyst Recommendation on TransCode Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for TransCode Therapeutics. Average target price of $10
TransCode Therapeutics Share Price Target
Get share price movements and forecasts by analysts on TransCode Therapeutics.
What analysts predicted
83.4%UPSIDE
Target Price
$10
Current Price
$1.66
Analyzed by
7 Analysts
Target
$10.00
TransCode Therapeutics target price $10, a slight upside of 83.4% compared to current price of $1.66. According to 7 analysts rating.
Indian Investors' Interest in TransCode Therapeutics Stock
Search interest for TransCode Therapeutics Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
TransCode Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
TransCode Therapeutics Annual Profit & Loss
All numbers in Millions USD
TransCode Therapeutics Quarterly Cash Flow
All numbers in Millions USD
TransCode Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on TransCode Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 596.6%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.6% return, outperforming this stock by 127.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, RNAZ stock has moved down by -18.0%
About TransCode Therapeutics
| Organisation | TransCode Therapeutics |
| Headquarters | 6 Liberty Square, Boston, MA, United States, 02109 |
| Industry | Biotechnology |
| CEO | Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. |
| E-voting on shares | Click here to vote |
Key Management of TransCode Therapeutics
Name | Title |
|---|---|
Dr. Michel Janicot PH.D. | Consulting Head of Translational Science |
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. | CEO & Executive Chairman of the Board |
Mr. Thomas A. Fitzgerald M.B.A. | CFO, Secretary, President, VP of Administration & Director |
Dr. Zdravka Medarova Ph.D. | Scientific Co-Founder & Chief Scientific Officer |
Dr. Anna Moore Ph.D. | Scientific Co-Founder, Scientific Advisor & Chair of Scientific Advisory Board |
Ms. Susan Duggan M.B.A., R.N. | Senior Vice President of Operations |
Dr. Daniel R. Vlock M.D. | Chief Medical Officer |
FAQs
What is TransCode Therapeutics share price today?
TransCode Therapeutics share price today is $1.66 as on at the close of the market. TransCode Therapeutics share today touched a day high of $1.72 and a low of $1.65.
What is the 52 week high and 52 week low for TransCode Therapeutics share?
TransCode Therapeutics share touched a 52 week high of $20.99 on and a 52 week low of $1.63 on . TransCode Therapeutics stock price today i.e. is closed at $1.66,which is 92.09% down from its 52 week high and 2.06% up from its 52 week low.
What is TransCode Therapeutics's market capitalisation today?
TransCode Therapeutics market capitalisation is $0.00T as on .
How to invest in TransCode Therapeutics Stock (RNAZ) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for TransCode Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TransCode Therapeutics Shares that will get you 0.9036 shares as per TransCode Therapeutics share price of $1.66 per share as on September 15, 2026 at 1:29 am IST.
What is the minimum amount required to buy TransCode Therapeutics Stock (RNAZ) from India?
Indian investors can start investing in TransCode Therapeutics (RNAZ) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in TransCode Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on TransCode Therapeutics share’s latest price of $1.66 as on September 15, 2026 at 1:29 am IST, you will get 6.0241 shares of TransCode Therapeutics. Learn more about
fractional shares .
What are the returns that TransCode Therapeutics has given to Indian investors in the last 5 years?
TransCode Therapeutics stock has given -100% share price returns and 29.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?